TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Generic drugmaker Mylan completes $1.75B acquisition in India

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

Thursday, Dec. 5, 2013, 12:01 a.m.
 

Generic drugmaker Mylan Inc. expanded its global manufacturing capability and portfolio of injectable medications with a $1.75 billion acquisition on Wednesday.

Cecil-based Mylan, one of the world's biggest generic pharmaceutical companies, said it completed the purchase of the Agila unit of Indian drugmaker Strides Arcolab Ltd.

The deal, first announced in February, gives Mylan 13 manufacturing plants in six countries and four research and development centers staffed by 400 scientists.

The addition of Agila's portfolio means Mylan offers more than 1,200 injectable drugs across the world, with another 900 products awaiting regulatory approvals, the company said.

Agila's foothold in several emerging markets, including Brazil, India and Southeast Asia, was attractive to Mylan.

“The acquisition of Agila will create a global injectables leader, expanding and strengthening Mylan's existing injectables platform and portfolio, and providing Mylan entry into exciting, new geographic markets,” CEO Heather Bresch said in a statement. “We believe we can generate significant growth from this business.”

Mylan will hold back $250 million in the deal on the condition that Agila satisfy U.S. regulators over problems of one of its Indian manufacturing plants.

In September, the Food and Drug Administration sent a so-called warning letter to Agila as a result of a June inspection at its Bangalore factory that turned up deficient procedures for preventing contamination of products.

Alex Nixon is a staff writer for Trib Total Media. He can be reached at 412-320-7928 or anixon@tribweb.com.

Add Alex Nixon to your Google+ circles.

Subscribe today! Click here for our subscription offers.

 

 

 


Show commenting policy

Most-Read Business Headlines

  1. Trax is affordable SUV option
  2. Renewed fears of Greek default whack stock market
  3. Mylan discounts speculation of a possible takeover by Teva
  4. Pa. employers shed 12,700 jobs in March; unemployment rate rises to 5.3 percent
  5. Glaxo to close Moon office, affecting 274 workers
  6. PPG axes 1,700 jobs as part of global restructuring
  7. Hearings set on new environmental rules for gas, oil drilling in Pa.
  8. Gas price slump has Consol Energy shedding jobs
  9. Celebrity chef backings, farm-to-table trend help healthy fast-food market thrive
  10. EU regulators challenge Google’s domain
  11. Retailer Etsy crafts successful IPO